Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2012-10-09
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate DELUSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-24 (study day 47.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate HALLUCINATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-24 (study day 47.0); relationship: NONE
severe
assessed
2026-08-18
Severe PROSTATE CANCER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-07 (study day 122.0); relationship: NONE
mild
assessed
2026-08-18
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-05 (study day 89.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.